Unleash iMM’s research excellence in immunity and infection through twinning to infect Lisbon and Portugal with its increase in competitiveness and innovation
WP1 - Project management The management team will ensure the achievement of TwinnToInfect objectives, milestones and deliverables in timely manner. Impact assessment strategy and monitoring throughout the project are also core activities of WP1. WP2 – Training, mentoring and international exposure of iMM Lisboa young researchers To capacitate iMM Lisboa young research and students community in order to root an ambitious, entrepreneurial and risk-taking spirit, through mentoring, various training activities and potentiating their international exposure. WP3 – Development of iMM Lisboa research potential - knowhow and experience exchange To effectively stimulate research excellence among research groups in the immunity and infection research field through the establishment of a sustainable collaborative network with the partnering institutions, through knowhow and experience exchange within the scientific community. WP4 - Strengthening the innovation and entrepreneurship ecosystem To build an innovation and entrepreneurship ecosystem at IMM by nurturing an entrepreneurial and risk-taking spirit among iMM Lisboa students and researchers and potentiating the integration of iMM Lisboa in the regional, national and European business communities. WP5 – Dissemination and communication The proper dissemination of the achievements under the scope of TwinnToInfect will be accomplished mainly through raising public and scientific awareness of the project and facilitating the interaction with scientific and non-scientific audiences. WP6 - Sustainability beyond the project The overall aim of this WP is to develop a strategy to support and sustain the collaborative research and innovation network cemented in TwinnToInfect project, in order to keep iMM at the forefront of biomedicine in Europe and at the core of the network of leading international institutions.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 692022